English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biomarin Pharmaceuticals
+
Technology/Innovation
Carol Ostrow
| Dec 28, 2017
BioMarin presents revised clinical data for hemophilia A treatment
+
Regulatory
Ruth de Jauregui
| Jun 8, 2017
BioMarin's Brineura gets European approval for treating CLN2 brain disease in children
+
Technology/Innovation
Chandra Lye
| May 4, 2017
Drug offers hope for children with rare brain disease
+
Regulatory
Caitlin Nordahl
| Apr 24, 2017
BioMarin, Par reach settlement on Kuvan
+
Technology/Innovation
Jeff Gantt
| Dec 18, 2016
BioMarin Pharmaceutical initiates phase 3 vosoritide trial
+
Community
Amanda Rupp
| May 11, 2016
BioMarin releases EMA grants for Batten disease treatment
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
